Merck Handed First Loss in Fosamax Bellweather Trials

The Merck Pharmacy in New York City 1897

A jury in New York City federal court has ruled that pharmaceutical giant Merck didn’t properly warn users about the risks associated with its osteoporosis drug Fosamax, according to a recent article from Reuters.

Read more...

Visit other PMG Sites: